Veracyte [VCYT] vs Thermo Fisher [TMO] Detailed Stock Comparison

Veracyte Inc.

NASDAQ
Loading...

Thermo Fisher Scientific Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Veracyte Inc. wins in 5 metrics, Thermo Fisher Scientific Inc. wins in 14 metrics, with 0 ties. Thermo Fisher Scientific Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Veracyte Inc. Thermo Fisher Scientific Inc. Better
P/E Ratio (TTM) 40.43 25.84 Thermo Fisher Scientific Inc.
Price-to-Book Ratio 2.01 3.31 Veracyte Inc.
Debt-to-Equity Ratio 3.03 82.91 Veracyte Inc.
PEG Ratio 0.06 2.29 Veracyte Inc.
EV/EBITDA 26.79 19.02 Thermo Fisher Scientific Inc.
Profit Margin (TTM) 12.83% 15.15% Thermo Fisher Scientific Inc.
Operating Margin (TTM) 17.50% 17.89% Thermo Fisher Scientific Inc.
EBITDA Margin (TTM) 17.50% 17.89% Thermo Fisher Scientific Inc.
Return on Equity 5.34% 13.52% Thermo Fisher Scientific Inc.
Return on Assets (TTM) 2.91% 5.00% Thermo Fisher Scientific Inc.
Free Cash Flow (TTM) $126.63M $6.29B Thermo Fisher Scientific Inc.
Dividend Yield N/A 0.38% N/A
1-Year Return 74.15% 22.27% Veracyte Inc.
Price-to-Sales Ratio (TTM) 5.11 3.86 Thermo Fisher Scientific Inc.
Enterprise Value $2.26B $214.76B Thermo Fisher Scientific Inc.
EV/Revenue Ratio 4.37 4.75 Veracyte Inc.
Gross Profit Margin (TTM) 72.51% N/A N/A
Revenue per Share (TTM) $7 $120 Thermo Fisher Scientific Inc.
Earnings per Share (Diluted) $0.82 $18.18 Thermo Fisher Scientific Inc.
Beta (Stock Volatility) 1.96 0.97 Thermo Fisher Scientific Inc.
Short % of Float 8.87% 1.22% Thermo Fisher Scientific Inc.

Veracyte Inc. vs Thermo Fisher Scientific Inc. Stock Performance Analysis

Loading Price Chart...

VCYT
TMO

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Veracyte Inc.1.88%9.46%45.59%38.83%1.99%14.89%
Thermo Fisher Scientific Inc.-1.69%3.89%2.45%-6.72%-18.35%-20.01%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Veracyte Inc.74.15%73.43%40.68%774.34%276.75%276.75%
Thermo Fisher Scientific Inc.22.27%-5.31%9.75%222.18%684.25%1,233.99%

Performance & Financial Health Analysis: Veracyte Inc. vs Thermo Fisher Scientific Inc.

MetricVCYTTMO
Market Information
Market Cap i$2.74B$174.55B
Market Cap CategoryMid capLarge cap
10 Day Avg. Volume i744,3892,356,220
90 Day Avg. Volume i891,9632,071,517
Last Close$48.70$473.95
52 Week Range$22.61 - $50.71$385.46 - $643.99
% from 52W High-3.96%-26.40%
All-Time High$86.03 (Feb 08, 2021)$672.34 (Dec 27, 2021)
% from All-Time High-43.39%-29.51%
Growth Metrics
Quarterly Revenue Growth0.19%0.06%
Quarterly Earnings Growth7.05%0.10%
Financial Health
Profit Margin (TTM) i0.13%0.15%
Operating Margin (TTM) i0.18%0.18%
Return on Equity (TTM) i0.05%0.14%
Debt to Equity (MRQ) i3.0382.91
Cash & Liquidity
Book Value per Share (MRQ)$16.50$141.96
Cash per Share (MRQ)$5.20$8.75
Operating Cash Flow (TTM) i$136.31M$8.29B
Levered Free Cash Flow (TTM) i$86.80M$5.51B
Dividends
Last 12-Month Dividend Yield iN/A0.38%
Last 12-Month Dividend iN/A$1.76

Valuation & Enterprise Metrics Analysis: Veracyte Inc. vs Thermo Fisher Scientific Inc.

MetricVCYT (Apr 26, 2026)TMO (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i40.4325.84
Forward P/E i18.8017.16
PEG Ratio i0.062.29
Price to Sales (TTM) i5.113.86
Price to Book (MRQ) i2.013.31
Market Capitalization
Market Capitalization i$2.74B$174.55B
Enterprise Value i$2.26B$214.76B
Enterprise Value Metrics
Enterprise to Revenue i4.374.75
Enterprise to EBITDA i26.7919.02
Risk & Other Metrics
Beta i1.960.97
Book Value per Share (MRQ) i$16.50$141.96

Financial Statements Comparison: Veracyte Inc. vs Thermo Fisher Scientific Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricVCYT (2025)TMO (2025)
Revenue/Sales i517.15M44.56B
Cost of Goods Sold i154.61M26.32B
COGS % of Revenue i29.9%59.1%
Gross Profit i362.53M18.24B
Gross Margin i70.1%40.9%
Research & Development i70.81M1.40B
Operating Income (EBIT) i78.28M8.11B
Operating Margin i15.1%18.2%
EBITDA i112.86M11.86B
EBITDA Margin i21.8%26.6%
Pre-Tax Income i68.20M7.31B
Pre-Tax Income % of Revenue i13.2%16.4%
Income Tax i1.85M547.00M
Income Tax % of Revenue i0.4%1.2%
Net Income (Profit) i66.35M6.72B
Profit Margin i12.8%15.1%

Balance Sheet & Liquidity Metrics

MetricVCYT (2025)TMO (2025)
Cash & Equivalents i362.58M9.85B
Total Current Assets i488.38M28.71B
Total Current Assets % of Revenue i94.4%64.4%
Total Current Liabilities i59.94M15.19B
Total Current Liabilities % of Revenue i11.6%34.1%
Long-Term Debt i35.60M35.85B
Long-Term Debt % of Revenue i6.9%80.5%
Total Shareholders Equity i1.31B53.54B
Retained Earnings i-377.63M59.16B
Retained Earnings % of Revenue i-73.0%132.8%
Property, Plant & Equipment i73.32M0

Cash Flow Statement Comparison

MetricVCYT (2025)TMO (2025)
Operating Cash Flow i111.92M7.82B
Operating Cash Flow % of Revenue i21.6%17.5%
Capital Expenditures i-9.68M-1.48B
Free Cash Flow i126.63M6.29B
FCF Margin i24.5%14.1%
Debt Repayment iN/A-3.51B
Common Stock Repurchase iN/A-3.00B

Short Interest & Institutional Ownership Analysis

MetricVCYTTMO
Shares Short i6.33M4.54M
Short Ratio i5.892.38
Short % of Float i8.87%1.22%
Shares Outstanding i79.36M371.62M
Float Shares i79.02M371.07M
% Held by Insiders i1.00%0.17%
% Held by Institutions i110.26%95.23%
% Held by Public i-11.26%4.60%

Dividend Analysis & Yield Comparison: Veracyte Inc. vs Thermo Fisher Scientific Inc.

MetricVCYTTMO
Last 12-Month Dividend iN/A$1.76
Last 12-Month Dividend Yield iN/A0.38%
3-Year Avg Annual Dividend iN/A$1.60
3-Year Avg Dividend Yield iN/A0.08%
3-Year Total Dividends iN/A$4.80
Ex-Dividend DateN/AMar 13, 2026